ESCO1 as a novel predictive biomarker and potential therapeutic target in renal cell carcinoma
The increased ESCO1 expression in renal tumor tissues might be a useful biomarker for prognosis of RCC patients. Knockdown of ESCO1 undermined proliferation, migration of renal cancer cells, and induced the apoptosis of renal cancer cells.
Authors
- S Zhang (ORCID: https://orcid.org/0009-0006-4839-3570)
- Yan‐Hong Cui (ORCID: https://orcid.org/0000-0002-4169-6521)
- Zhifang Zhang (ORCID: https://orcid.org/0000-0002-1047-2402)
- Weinan Wang (ORCID: https://orcid.org/0009-0000-0384-5269)
- Yang Teng (ORCID: https://orcid.org/0000-0002-2564-2662)
- Sixiu Li (ORCID: https://orcid.org/0000-0002-3373-2975)
- Xueli Yuan
- Jianye Li
Institutions
- Harbin Medical University (CN)
- China National Biotechnology (China) (CN)
- Air Force General Hospital PLA (CN)
Publication Details
- Journal
- Tumori Journal
- Published
- 2025-02-16
- DOI
- https://doi.org/10.1177/03008916241311395
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Fourth Military Medical University